Researcher: Video Games Possibly More Analgetic Than Drugs
Why Pain Medication Use is Really on the Rise
Pharmacologic management of neuropathic pain: evidence-based recommendations
Anticonvulsants
FDA Advisory Members Agree Antiepileptics Pose Suicidality Risk, Nix Need for Black-Box Warning
Pregabalin Offers Long-Term Relief of Painful Neuropathy
Health Canada warns of serious skin reactions in patients taking carbamazepine
Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label Trial
FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior with Antiepileptic Medications
FDA Analysis Showed PatientsReceiving Antiepileptic Drugs Had Approximately Twice The Risk of Suicidal Behavior Or Ideation
Serum Uric Acid and Lipid Levels While Taking Topiramate for Migraine
Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study
Treatment of trigeminal neuralgia with low doses of topiramate
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam
Efficacy of pregabalin in the treatment of trigeminal neuralgia
Pregabalin in neuropathic pain: A more "pharmaceutically elegant" gabapentin?
New Data Published In Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures In Patients With Epilepsy
Antiepileptic Drugs May Impair Bone Growth in Children
Dramatic Weight Loss with Levetiracetam
Pregabalin: An Antiepileptic Agent Useful for Neuropathic Pain
Experts Call For Urgent Research Into Antiepileptic Drugs Given To Children
Long-Term Use of Antiepileptic Drugs May Lower Bone Mineral Density
New Drug Shows Promise for Treating Epileptic Seizures.
Hypersensitivity to Anticonvulsants May Predict Reaction to Tricyclics
Painful posttraumatic trigeminal neuropathy: a case report of relief with topiramate.
Enzyme-Inducing Antiepileptic Drugs Associated with Lower Vitamin D in Men
Tolerance to Antiepileptic Drugs May Develop Over Time
Antiepileptics Have Low Risk of Stevens-Johnson Syndrome
Trileptal May Cause Serious Dermatologic Reactions
Gabapentin and Hepatotoxicity
FDA Approvals: Angiomax, Lyrica, Zmax
Anticonvulsant drugs for acute and chronic pain
Gabitril Off-Label Use Associated with Risks of New-Onset Seizures
Levetiracetam (Keppra) for the Treatment of Trigeminal Neuralgia
Glaxo Recalls Lamictal Kits in US Due to Wrong Dose
Tiagabine Reduces Neuropathic Pain
Antidepressants
Antidepressants for neuropathic pain
SMFM: No Pregnancy Risks Found with Antidepressant Use
Antidepressant Agents for the Treatment of Chronic Pain and Depression
Reversible Facial Myoclonus with Topiramate Therapy for Epilepsy
US FDA Says Lilly's Cymbalta Promotion Misleading
How Anti-Depressants Create New Brain Cells
Antidepressants: Another weapon against chronic pain
Antidepressant Response Strongly Influenced by Genetics, Ethnicity
Thyroid Supplementation Enhances Antidepressant Response.
Antidepressants Linked to Increased Risk of Diabetes in High-Risk Patients
Cymbalta May Aggravate Preexisting Liver Disease
Tricyclic antidepressants: Weapons against chronic pain
FDA Warns Against Use of Migraine Drugs With Certain Antidepressants
Adjunctive treatments
Adjunctive Agents in the Management of Chronic Pain
Bone Loss and drugs for TN
Novel Drug Shows "Very Promising" Results as Osteoporosis Treatment
SSRI Use in Older Women Linked to Accelerated Hip Bone Loss
Lower Bone Mineral Density Found in Older Men Using SSRIs
Selective Serotonin Reuptake Inhibitors Increase Fracture Risk in Older Adults
Antiepileptic Drugs May Impair Bone Growth in Children
Long-Term Use of Antiepileptic Drugs May Lower Bone Mineral Density
Osteoporosis and Anticonvulsants
Merck Wins Approval for Combined Fosamax Treatment
Breakthrough Pain
Dose Finding for Breakthrough Pain
Optimizing Opioid Treatment for Breakthrough Pain
Diabetic Neuropathy
Lacosamide Promising in Relief of Painful Diabetic Neuropathy
Lacosamide Demonstrates Strong Potential for Management of Diabetic Neuropathic Pain: Presented at APS
Cymbalta, new drug for Diabetic Neuropathy
Drugs on the Internet
A Guide to Buying Prescription Drugs on the Internet
FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet
FDA Warns of Counterfeit Prescription Drugs Purchased Online
Emergency Treatment for TN
Acute pain management in emergency medicine
Pain-relieving effects of intravenous ATP in chronic intractable orofacial pain: an open-label study.
FDA/DEA Warnings, Changes and Recalls
FDA Advisory Members Agree Antiepileptics Pose Suicidality Risk, Nix Need for Black-Box Warning
ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
FDA Approves Relistor for Opioid-Induced Constipation
FDA warns of deaths in kids treated with Botox
FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior with Antiepileptic Medications
Fentanyl Patch Recall Expanded
Fentanyl Pain Patch Recalled
FDA MedWatch - Carbamazepine - Dangerous Or Fatal Skin Reactions Significantly More Common In Patients With A Particular Human LeukocyteAntigen (HLA) Allele
Deaths Related to Fentanyl Patch Misuse Spark Second Public Health Advisory
Second Safety Warning on Fentanyl Skin Patch
FDA Safety Changes: Section regarding Tegretol/XR
FDA Safety Changes: Antidepressants and Tykerb
FDA Safety Changes: Cymbalta
FDA Safety Changes: Effexor, Effexor XR, Depakene
FDA Safety Changes: Kenalog-10 and Kenalog-40, Depacon, Depakene
FDA Safety Changes: Depakote and Strattera
FDA Safety Changes: Allegra, Cymbalta, Concerta
FDA Safety Changes: Lopressor, Lamictal, Abilify
FDA Warns Against Use of Migraine Drugs With Certain Antidepressants
FDA Issues Public Health Advisory for Fentora
FDA Warning On Codeine Use By Nursing Mothers
Recall of Able Drugs. Click for list of drugs.
Drugs to warn of sleep dangers
Unsafe Drugs? HealthandAge.com
DEA Revises Rule on Prescribing Painkillers
Avinza Interaction With Alcohol May Be Lethal, FDA Warns
Glaxo Recalls Lamictal Kits in US Due to Wrong Dose
Generic Drugs
Does generic lamotrigine lead to larger variations in plasma concentrations?
First-Time Generic Approvals: Combunox, Dilantin, Antizol - Section on Dilantin
First-Time Generic Approvals: Trileptal, Vicoprofen, Exelon
Myths and Facts About Generic Drugs
Generic Drugs, Are They As Good as Brand-Names?
Imaging
Boxed Warning Added for Gadolinium-Based Contrast Agents
Medical Care for Patients
Medical Care, Caring for Patients
Medical Marijuana
Medical Pot Ineffective as Acute Pain Treatment
Marijuana May Be Effective for Neuropathic Pain
Low-dose pot eases pain while keeping mind clear
An Alternative to Medicinal Marijuana: Nerve agents Stimulated cannabinoid receptors in mice, offering pain relief without side effects
Smoked Cannabis Proven Effective In Treating Neuropathic Pain
Dosing Medical Marijuana: Rational Guidelines on Trial in Washington State
Methadone
Therapeutic Levels of Methadone Can Cause Sudden Death
Miscellaneous Drug Uses
Tramadol for neuropathic pain
Non-antiepileptic drugs for trigeminal neuralgia
The Truth About Painkillers
Successful treatment of trigeminal neuralgia with milnacipran.
Newly Identified Drug Relieves Suffering
Chronic administration of ketamine for analgesia.
Recent Advances in Nonopioid Treatment of Pain
Drug combo packs more relief for chronic nerve pain, scientists say
Namenda and Facial Pain
Ketamine: a misunderstood analgesic?
Migraine drug eases severe face pain
Subcutaneous Sumatriptan Treats Refractory Trigeminal Neuralgia
Response of Neuropathic Trigeminal Pain to the Combination of Low-Dose Nalbuphine Plus Naloxone in Humans
MS - Multiple Sclerosis
Low-dose gabapentin in combination for TN and MS
Misoprostol in the Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis
Neuropathic Pain
Analgesia Mediated by the TRPM8 Cold Receptor in Chronic Neuropathic Pain.
Off Label Drug Use
Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Off-label Ketamine Use Studied for Pain Management
Opiods
Frequent Opioid Use May Increase Risk of Chronic Migraine
Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain
Chronic Pain Meds Unlikely to Cause Addiction
Physical Signs of Severe Pain Separate Drug Seekers from Legitimate Patients
ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
Review of oral oxymorphone in the management of pain
Oral Prolonged Release Oxycodone / Naloxone Combination Reduces Opioid-induced Constipation In Severe Chronic Pain Patients, With No Loss Of Analgesia
Risks for Painkiller Abuse Do Not Outweigh Benefits in Chronic Pain
Opioid-Induced Sexual Dysfunction: Causes, Diagnosis, & Treatment
Provider Prescribing Patterns and Perceptions: Identifying Solutions to Build Consensus on Opioid Use in Pain Management— A Roundtable Discussion
FDA Approves Relistor for Opioid-Induced Constipation
Prescription Drug Abuse Threatens Availability of Pain Medication
Strong Painkillers only moderately effective against chronic pain
What Are We Afraid Of? Barriers to Providing Adequate Pain Relief
Laws and Regulations Affecting Opioid Prescribing
Opioid-Induced Pain Sensitivity
The Intersection of Pain Management and Addictive Illness
OxyContin doesn't cause addiction. Its abusers are already addicts.
The use of ketamine as adjuvant therapy to control severe pain.
Pain Patients Should Not be Punished for Opioid Medication Abuse or Addiction
Oxycodone: a review of its use in the management of pain
Physician attitudes toward opioid prescribing for patients with persistent noncancer pain.
Physicians Gain New Tool To Better Manage Acute And Chronic Pain
Signal Transduction of Pain: Implications for Opioid Therapy
Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia
Strong Pain-killing Drugs Without The Addiction
Fatalities Associated with Fentanyl and Co-administered Cocaine or Opiates.
FDA Issues Public Health Advisory for Fentora
Improper Use of Fentora Linked to Patient Deaths
Optimizing Opioid Treatment for Breakthrough Pain
Pain patient's behavior tips off opioid abuse
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study
Maximizing Safety with Methadone & Other Opioids
Overcoming Opiophobia & Doing Opioids Right
Oxycodone Safety Handout For Patients
Can levorphanol be used like methadone for intractable refractory pain?
Tailoring Chronic Pain Treatment to the Patient: Long-Acting, Short-Acting, and Rapid-Onset Opioids
Scientists get a fix on methadone risks
Opioids for Chronic Nonterminal Pain
Potential New Pain Killer Developed
Methadone-Related Fatalities Underscore Need for Careful Dosing
Checklist Helps Identify Inappropriate Opioid Use
Methadone Analgesia Safety Overview & Patient Instructions Handout
New opioid formulation fits nicely into rotation
Recent study confirms warning signs of painkiller abuse
Overview of Oral Modified-Release Opioid Products for the Management of Chronic Pain
Fentanyl Effervescent Buccal Tablets in Patients With Chronic Pain
Combining Methadone With Other Long-acting and Short-acting Opioids for Pain Management
The Pharmacology of Fentanyl and Its Impact on the Management of Pain
Painful Choices: Physicians Challenged by Quest to End Suffering
At the debate's core is the love/hate affair with the powerful class of pain medications known as opioids
Opioid Therapies for the Management of Pain
FDA OKs the Pain Drug Opana
Cephalon Receives Approvable Letter For FENTORA(TM) (fentanyl Buccal Tablet) For Management Of Breakthrough Pain In Patients With Cancer
Nalbuphine a Safe, Effective Long-Term Therapy for Severe Chronic Pain
Plenty of pills and potential for abuse: USA Today
The Killer Cure: A Deadly Dose; FDA-Approved Language Called "Extremely Dangerous"
Transporter is possible target for safer pain medicine.
Opiods Can Relieve Nerve Pain
PHN - Post-Herpetic Neuralgia
Shingles, adult whooping cough vaccines underused
Desipramine More Cost-Effective Than Newer Drugs for Postherpetic Neuralgia
NeurogesX Announces Presentation Of Positive Phase 3 Clinical Data At The Second International Congress On Neuropathic Pain Meeting (NeuPSIG)
Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine
NeurogesX Phase 3 Study in Post-Herpetic Neuralgia Meets Primary Endpoint
US Panel Strongly Recommends Shingles Vaccine
Herpes Zoster Vaccine Effective, but Is It Cost-effective?
IV Acyclovir Plus Oral Valacyclovir Helpful in Postherpetic Neuralgia
NPR: Experimental Vaccine Proves Effective Against Shingles
Shingles Vaccine and Post-Herpetic Neuralgia
The first oral drug approved to relieve both postherpetic neuralgia and neuropathic pain associated with peripheral neuropathy
Pain Pathways and Pain Blockers
Patient-Controlled Analgesia in Chronic Pain Patients: Experience with a New Device Designed to be Used with Implanted Programable Pumps
Battlefield Advances - Smart Painblockers
Neuroscientists explain inner workings of critical pain pathway
Pain Perception
Pain perception: Sex and drugs
Pregnancy & Nursing
Valproate Taken During Pregnancy May Increase Risk of Fetal Malformations
FDA Warning On Codeine Use By Nursing Mothers
Teratology Society Calls for Immediate Change in Pregnancy Labeling for Medications
Few Congenital Malformations Associated With Levetiracetam Use in Pregnancy
NEAD: In Utero Exposure To Valproate Linked to Poor Cognitive Outcomes in Kids
Glaxo Warns of Birth Defect From Antiepileptic Drug
Valproate Should Not Be Used as First-Line Therapy in Women of Childbearing Age
Maternal Use of Anticonvulsants Increases Risk of Craniostenosis in Offspring
Research and Study
Patient-Controlled Analgesia in Chronic Pain Patients: Experience with a New Device Designed to be Used with Implanted Programable Pumps
Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label Trial
Chronic pain seen altering how brain works
Clinical trial outcome in neuropathic pain
New Research Studies
Novel Treatments in the Pipeline for Neuropathic Pain
Side Effects
Tips to Prevent Adverse Drug Events in Older Adults
Serum Uric Acid and Lipid Levels While Taking Topiramate for Migraine
Driving Abilities Not Impaired By Moderate, Long-Term Pain Medication Use, Study Suggests
Treatment of Pain- Medical Management-Guidelines
Evidence-based approach to the medical management of trigeminal neuralgia.
EFNS guidelines on pharmacological treatment of neuropathic pain.
Pharmacologic Treatment of Chronic and Breakthrough Pain
Trying To Control Pain Can Be A Double-edged Sword, Say Scientists
Are Patient Ratings Of Chronic Pain Services Related To Treatment Outcome?
New Perspectives in Chronic Pain: An Expert Interview With Perry G. Fine, MD
Highlights of the 22nd Annual Meeting of the American Academy of Pain Medicine
Pain Treatment Topics E-Briefing
Tips for Treating Pain
Dr. Donohue: Medicines can control many facial tics |
